Amphastar Pharmaceuticals

Amphastar Pharmaceuticals, Inc. was founded in 1996 and is headquartered in California. It is a recognized biopharmaceutical company that uses state-of-the-art, cGMP-compliant facilities to develop, manufacture, and market injectable, intranasal, and inhalation products. In addition to its corporate headquarters, Amphastar operates five manufacturing plants in the United States, China, and Europe, as well as a cutting-edge new drug research center. The company currently produces over 20 commercial products while continuing to develop generic and branded portfolios targeting large markets with high technical entry barriers. Amphastar's long-standing partnerships with major U.S. group purchasing organizations, retailers, and pharmaceutical wholesalers enable it to establish significant market share upon the launch of new products.